ClearBridge Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

ClearBridge Investments’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-27,000	Closed	-$1.72M	–	1218
2017 Q1	$1.72M	Sell	27,000 -25,000	-48%	-$1.52M	﹤0.01%	632
2016 Q4	$2.31M	Hold	52,000	–	–	﹤0.01%	606
2016 Q3	$1.88M	Buy	+52,000	New	+$1.12M	﹤0.01%	626
2014 Q4	–	Sell	-242	Closed	-$11K	–	1193
2014 Q3	$11K	Hold	242	–	–	﹤0.01%	1098
2014 Q2	$10K	Sell	242 -590	-71%	-$30.4K	﹤0.01%	1124
2014 Q1	$58K	Buy	832 +422	+103%	+$31K	﹤0.01%	943
2013 Q4	$25K	Hold	410	–	–	﹤0.01%	1000
2013 Q3	$25K	Buy	+410	New	+$29.1K	﹤0.01%	969

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ClearBridge Investments's CLVS Position: Q2 2017 in Review

ClearBridge Investments sold out of Clovis Oncology, Inc. (CLVS) in Q2 2017, closing a stake of 27,000 shares — an estimated $1.72M sold.

ClearBridge Investments first reported a position in CLVS in Q3 2013 and held it in 8 quarters. The position peaked at $2.31M in Q4 2016. 271 funds tracked by Wall St. Rank hold CLVS as of Q2 2017.

ClearBridge Investments reported no remaining Clovis Oncology, Inc. position as of Q2 2017 after selling out during the quarter.
ClearBridge Investments sold 27,000 Clovis Oncology, Inc. shares in Q2 2017, an estimated $1.72M.
ClearBridge Investments first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 8 quarters.
ClearBridge Investments's Clovis Oncology, Inc. position peaked at $2.31M in Q4 2016.
271 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2017.

Based on ClearBridge Investments's 13F filing for Q2 2017, filed 14 Aug 2017.